PET-Adapted First-Line Therapy With Nivolumab for Advanced Hodgkin Lymphoma

Abroad (travel likely)RecruitingPHASE2

Conditions

Hodgkin Lymphoma · Hodgkin Disease · Advanced Hodgkin Lymphoma

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

National Medical Research Center for Hematology, Moscow, Russia
Contact: Study coordinator (Anna A Kravtsova, MD) · kravtsovaanna95@gmail.com

Study leads

Evgeny E Zvonkov, MD, PhD
Study Director
National Medical Research Center for Hematology

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Role of Spectral CT in the Evaluation of Cardiotoxicity in Patients With Hodgkin's Lymphoma and Diffuse Large B-cell Lymphoma Treated With Anthracyclines

Cardiac Imaging · Cardiac Imaging Techniques · Lymphoma

Abroad (travel likely)Recruiting

Bologna, Italy

Personalized Reduction of Chemotherapy Intensity Through ctDNA Evaluation for the Treatment of Patients With Advanced Hodgkin Lymphoma

Advanced Hodgkin Lymphoma · Classic Hodgkin Lymphoma · Lugano Classification Stage III Hodgkin Lymphoma AJCC v8

Abroad (travel likely)RecruitingPHASE2

Irvine, United States · Palo Alto, United States

A Phase II Trial of Mosunetuzumab, Polatuzumab, Tafasitamab, and Lenalidomide in Patients With Relapsed B-cell NHL

Hodgkin Lymphoma · B-Cell Lymphoma · Relapsed B-cell NHL

Abroad (travel likely)RecruitingPHASE2

Houston, United States

Chemoradiotherapy With Targeted Immunotherapy in Pediatric Lymphoma

Non-hodgkin Lymphoma · Hodgkin Lymphoma

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Gainsville, United States